arrow
C

Carlos Alfaro

university of navarra
H指数:32
被引数:5,738

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

肿瘤产生的CXCR1和CXCR2趋化因子受体激动剂诱导中性粒细胞胞外诱捕网干扰免疫细胞毒性

IMMUNITY
IF26.3
2020-05-01476
OAAI
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
2018-09-2935
OAAI
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients

晚期癌症患者的联合免疫疗法,包括肿瘤内多聚ICLC,树突状细胞疫苗接种和放疗

2018-05-01116
OAAI
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients

血清interleukin-8 (IL-8) 水平的变化反映并预测黑色素瘤和非小细胞肺癌患者对anti-PD-1治疗的反应

2017-08-01364
OAAI
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)

肿瘤产生的Interleukin-8吸引人类髓源性抑制细胞并引发中性粒细胞胞外陷阱 (NETs) 的挤出

2016-07-31333
OAAI
Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice

Nivolumab和Urelumab增强了Rag2-/-IL2Rγnull免疫缺陷小鼠中植入的人T淋巴细胞的抗肿瘤活性

2015-08-31148
OAAI
Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag24-/-IL2Rynull immunodeficient mice
2015-08-011
PRE
Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins

血清Interleukin-8反映了多种组织来源的恶性肿瘤的肿瘤负荷和治疗反应

2014-11-13213
OAAI
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

tremelimumab CTLA-4阻断肝细胞癌和慢性丙型肝炎患者的临床试验

2013-07-01824
PREAI
CD8 T Cell Priming in the Presence of IFN-α Renders CTLs with Improved Responsiveness to Homeostatic Cytokines and Recall Antigens: Important Traits for Adoptive T Cell Therapy
2012-10-0144
OAAI